View profile

Medical Marijuana, Hemp & CBD – Irresistible Opportunity

To view this email in your browser click here.

Internet Bull Report - Discovering Remarkable Opportunities

August 19 · Issue #35 · View online
Internet Bull Report is a financial newsletter that uncovers remarkable equities and special situations that offer potential epic returns.

To view this email in your browser click here.

 “I have no special talent. I am only passionately curious.” - Albert Einstein
Last week, Corona beer maker Constellation Brands ($STZ) announced it will infuse $4 billion US into Canada’s top cannabis producer Canopy Growth ($WEED). This marks the biggest investment ever in the industry and Constellation stated they wanted to capitalize on the “booming demand” for all things, marijuana.
Canopy said it will use the proceeds to expand and gain exposure to the nearly 30 countries likely to approve medical marijuana in the next year or two. “This deal marks the end of the warm-up in the marijuana sector (…) It’s fully go-time”Canopy Founder and CEO Bruce Linton stated.
It says a lot that Bank of America Merrill Lynch financed the deal. No doubt this will be only the beginning of many more mega deals to be announced.
Being a Medical Doctor with a flair for medicine, technology and entrepreneurship, the marijuana space caught my attention a few years back after having read some studies on how CBD had helped some patients with Alzheimer’s Disease (AD). There is some interesting evidence at the laboratory level that certain components of cannabis may be able to target the underlying processes behind dementia, particularly AD.
The more I studied up on CBD the more intrigued I became.
IBR has worked with a handful of marijuana companies and this certainly helped in laying a foundation for my thoughts and expanding my horizons globally as to just how big this opportunity will be. 📈
There is a plethora of information available on the net about the benefits of CBD, but be wary as most is not backed by science - yet.
Much more rigorous, high-quality research is needed to answer questions about CBD’s legitimate therapeutic uses and – critically – its potential harms.
I plan to be a part in helping to make that evidence happen in a significant way by spearheading some pre-clinical work. More on this very soon…🔬
I will be writing frequently about the sector and all the good (and bad) it has to offer.
I look forward to bringing many exciting marijuana deals to your attention - and soon, my very own line of CBD products under the Dr. Anna’s brand. 😉 (Can’t wait to share more with you!)
P.S. For information on how you can be an early investor (pre exchange traded), please send an email to:
P.P.S. If you have a startup in the MJ sector and are looking for a strategic partner, feel free to reach out to: 
Recent Posts:
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue